MHMaya Harary

Maya Harary

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maya Harary has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Histopathologic Considerations for Indication of Cochlear Implant for Patients With Vestibular Schwannoma

    by Shinya Ohira, Ivan A. Lopez, Maya Harary, Maureen Laufer, Gail Ishiyama, Gregory P. Lekovic, Akira Ishiyama

    Objective: Predicting cochlear implant (CI) outcomes in patients with vestibular schwannoma (VS) is challenging, even when the cochlear nerve remains anatomically intact. This study examined how cochlear and neural pathology relate to premortem audiometric findings, pure-tone average (PTA) and speech discrimination score (SDS), to explore histopathologic conditions that may be relevant to CI candidacy. Methods: Temporal bones labeled as “acoustic neuroma” were selected from the House Ear Institute Temporal Bone Registry. Twenty-eight patients (34 ears) with well-preserved cochlear structures were included. Clinical data, including audiometry, surgical history, and surgical approach, were reviewed. Histologic analysis assessed residual tumor, fundal involvement, and the status of cochlear hair cells and spiral ganglion cells (SGCs). Pathology was correlated with clinical and audiometric features. Results: Among 34 specimens from 28 patients, 7 were from nonsurgical cases and 27 from surgical cases. In cases with preserved hearing (PTA ≤60 dB or SDS ≥60%), spiral ganglion cell (SGC) counts exceeded 20,000, and hair cells were well preserved. Cases with severe PTA elevation commonly showed hair cell injury, yet SGCs remained partially preserved. In contrast, reduced SDS was consistently associated with SGC loss. After a translabyrinthine approach, SGCs and hair cells were nearly absent within 3 to 27 months in most cases, and cochlear ossification was observed in cases surviving beyond 50 months. In all cases with tumor extension into the fundus of the internal auditory canal, hearing was completely lost, and both hair cells and SGCs showed severe degeneration. Conclusion: SDS may parallel SGC status in VS, possibly more closely than PTA. These findings suggest that early tumor removal before fundal extension and preservation of the cochlear nerve may be associated with cochlear and neural integrity, which could be relevant for future CI candidacy.

  • Safety and Efficacy of Repeat Surgery for Recurrent Craniopharyngiomas: A RAPID Consortium Collaboration

    by Ryan M. Shih, Maya Harary, Marvin Bergsneider, Marilene Wang, Anthony P. Heaney, Kyle C. Wu, Daniel M. Prevedello, James J. Evans, Michael R. Chicoine, Albert H. Kim, et al.

    BACKGROUND AND OBJECTIVES: Craniopharyngiomas (CPs) recur in 20% to 50% of cases after initial management. To date, there are no large multi-institutional series investigating outcomes in patients receiving surgery for recurrent CP. Here, we leverage the Registry of Adenomas of the Pituitary and Related Disorders to analyze outcomes after surgical treatment of recurrent CP. METHODS: Demographic, clinical, radiographic, surgical, and outcome variables were analyzed for 483 patients receiving surgery for primary or recurrent CP across 16 US-based academic skull-base centers comprising the Registry of Adenomas of the Pituitary and Related Disorders consortium from 2000 to 2024. RESULTS: Among the 483 patients, 360 (74.5%) had primary CP and 123 (25.5%) had recurrent CP. The recurrent cohort was younger at initial diagnosis ( P adj < .01) and recurrence ( P adj = .02). Adamantinomatous CPs were more common in the recurrent cohort but not significantly so, and 33.3% of cases had prior radiation therapy. Recurrent cases had more frequent preoperative endocrine dysfunction and hormone replacement ( P adj < .01). Patients with recurrent CP had less frequent suprasellar tumor extension ( P adj = .04) and more frequent preinfundibular/transinfundibular over retroinfundibular localization ( P adj = .02). There were no differences in operative approach; endoscopic endonasal surgery was the most common, and procedures achieved similar distributions of gross and subtotal resection in both cohorts ( P adj = .30) with similar low frequencies of unplanned reoperation and surgical complications. New postoperative arginine vasopressin deficiency (in patients without preoperative arginine vasopressin deficiency) was more common in the primary cohort ( P adj = .04), but long-term follow-up demonstrated similar frequencies of endocrine dysfunction in both cohorts and comparably low rates (P adj = .17). CONCLUSION: This study provides the largest comparative evaluation of patients undergoing surgery for recurrent vs primary CP. Despite prior treatment, patients with recurrent CP achieved comparable resection outcomes with similar rates of neuroendocrine dysfunction. These findings indicate surgical resection remains a safe and efficacious option for recurrent CP, especially as emerging targeted therapies become available.